Further evidence on the effect of vitamin E on the cholesterol distribution in lipoproteins with special reference to HDL subfractions

Earlier claims that oral administration of alpha-tocopherol results in significant and considerable increase in the serum total HDL concentration could not be substantiated. The present investigation does, however, show that lipoproteins are affected by alpha-tocopherol in other ways, the main effec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of clinical pathology 1983-05, Vol.79 (5), p.604-606
Hauptverfasser: Serfontein, W J, Ubbink, J B, de Villiers, L S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 606
container_issue 5
container_start_page 604
container_title American journal of clinical pathology
container_volume 79
creator Serfontein, W J
Ubbink, J B
de Villiers, L S
description Earlier claims that oral administration of alpha-tocopherol results in significant and considerable increase in the serum total HDL concentration could not be substantiated. The present investigation does, however, show that lipoproteins are affected by alpha-tocopherol in other ways, the main effects being an increase in LDL-cholesterol and also in the HDL3-V cholesterol, an HDL3-subfraction determined by polyacrylamide gel electrophoresis. The established lipoprotein risk indices (LDL/HDL and HDL3/HDL2 ratios) were unfavorably affected as a result of alpha-tocopherol treatment. It is concluded that on the basis of available evidence, there is no reason to believe that alpha-tocopherol has a role to play in the prevention and treatment of atherosclerotic disease.
doi_str_mv 10.1093/ajcp/79.5.604
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80439548</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80439548</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-65747d21dfb2c473f5deff474b76edcb8ad2b6b61770bd2668495435a7e104843</originalsourceid><addsrcrecordid>eNo9kD1v2zAQhokiges6GTsW4JRNDr8kSmPhxk0AA12ameDHCWYgiSpJuegfyO8u3biZDuA9d_fyQegzJVtKOn6vX-x8L7ttvW2I-IDWtBO8kpKxK7QmhLCqo5J_RJ9SeiGEspaIFVo1LZc142v0ul9iPkLEcPIOJgs4TLg8YOh7sBmHHp981qOf8MP_lj2GAVKGGAbsfMrRmyX70izQ4Ocwx5DBTwn_9vmI0wzW6wFH6CH-u5ADfvx2wGkxfdT2PJlu0HWvhwS3l7pBz_uHn7vH6vDj-9Pu66GyrG1z1dRSSMeo6w2zQvK-diWnkMLIBpw1rXbMNKahUhLjWNO0oqsFr7UESkQr-Abdve0tGX8t5RNq9MnCMOgJwpJUscPLRFvA6g20MaRUsqs5-lHHP4oSdfauzt6V7FStivfCf7ksXswI7p2-iOZ_Af8wgUI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80439548</pqid></control><display><type>article</type><title>Further evidence on the effect of vitamin E on the cholesterol distribution in lipoproteins with special reference to HDL subfractions</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Serfontein, W J ; Ubbink, J B ; de Villiers, L S</creator><creatorcontrib>Serfontein, W J ; Ubbink, J B ; de Villiers, L S</creatorcontrib><description>Earlier claims that oral administration of alpha-tocopherol results in significant and considerable increase in the serum total HDL concentration could not be substantiated. The present investigation does, however, show that lipoproteins are affected by alpha-tocopherol in other ways, the main effects being an increase in LDL-cholesterol and also in the HDL3-V cholesterol, an HDL3-subfraction determined by polyacrylamide gel electrophoresis. The established lipoprotein risk indices (LDL/HDL and HDL3/HDL2 ratios) were unfavorably affected as a result of alpha-tocopherol treatment. It is concluded that on the basis of available evidence, there is no reason to believe that alpha-tocopherol has a role to play in the prevention and treatment of atherosclerotic disease.</description><identifier>ISSN: 0002-9173</identifier><identifier>EISSN: 1943-7722</identifier><identifier>DOI: 10.1093/ajcp/79.5.604</identifier><identifier>PMID: 6837523</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Arteriosclerosis - drug therapy ; Cholesterol - analysis ; Cholesterol, HDL ; Cholesterol, LDL ; Electrophoresis, Polyacrylamide Gel ; Humans ; Lipoproteins, HDL - analysis ; Lipoproteins, HDL - blood ; Lipoproteins, LDL - analysis ; Male ; Vitamin E - pharmacology ; Vitamin E - therapeutic use</subject><ispartof>American journal of clinical pathology, 1983-05, Vol.79 (5), p.604-606</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-65747d21dfb2c473f5deff474b76edcb8ad2b6b61770bd2668495435a7e104843</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6837523$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Serfontein, W J</creatorcontrib><creatorcontrib>Ubbink, J B</creatorcontrib><creatorcontrib>de Villiers, L S</creatorcontrib><title>Further evidence on the effect of vitamin E on the cholesterol distribution in lipoproteins with special reference to HDL subfractions</title><title>American journal of clinical pathology</title><addtitle>Am J Clin Pathol</addtitle><description>Earlier claims that oral administration of alpha-tocopherol results in significant and considerable increase in the serum total HDL concentration could not be substantiated. The present investigation does, however, show that lipoproteins are affected by alpha-tocopherol in other ways, the main effects being an increase in LDL-cholesterol and also in the HDL3-V cholesterol, an HDL3-subfraction determined by polyacrylamide gel electrophoresis. The established lipoprotein risk indices (LDL/HDL and HDL3/HDL2 ratios) were unfavorably affected as a result of alpha-tocopherol treatment. It is concluded that on the basis of available evidence, there is no reason to believe that alpha-tocopherol has a role to play in the prevention and treatment of atherosclerotic disease.</description><subject>Adult</subject><subject>Arteriosclerosis - drug therapy</subject><subject>Cholesterol - analysis</subject><subject>Cholesterol, HDL</subject><subject>Cholesterol, LDL</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Humans</subject><subject>Lipoproteins, HDL - analysis</subject><subject>Lipoproteins, HDL - blood</subject><subject>Lipoproteins, LDL - analysis</subject><subject>Male</subject><subject>Vitamin E - pharmacology</subject><subject>Vitamin E - therapeutic use</subject><issn>0002-9173</issn><issn>1943-7722</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kD1v2zAQhokiges6GTsW4JRNDr8kSmPhxk0AA12ameDHCWYgiSpJuegfyO8u3biZDuA9d_fyQegzJVtKOn6vX-x8L7ttvW2I-IDWtBO8kpKxK7QmhLCqo5J_RJ9SeiGEspaIFVo1LZc142v0ul9iPkLEcPIOJgs4TLg8YOh7sBmHHp981qOf8MP_lj2GAVKGGAbsfMrRmyX70izQ4Ocwx5DBTwn_9vmI0wzW6wFH6CH-u5ADfvx2wGkxfdT2PJlu0HWvhwS3l7pBz_uHn7vH6vDj-9Pu66GyrG1z1dRSSMeo6w2zQvK-diWnkMLIBpw1rXbMNKahUhLjWNO0oqsFr7UESkQr-Abdve0tGX8t5RNq9MnCMOgJwpJUscPLRFvA6g20MaRUsqs5-lHHP4oSdfauzt6V7FStivfCf7ksXswI7p2-iOZ_Af8wgUI</recordid><startdate>198305</startdate><enddate>198305</enddate><creator>Serfontein, W J</creator><creator>Ubbink, J B</creator><creator>de Villiers, L S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198305</creationdate><title>Further evidence on the effect of vitamin E on the cholesterol distribution in lipoproteins with special reference to HDL subfractions</title><author>Serfontein, W J ; Ubbink, J B ; de Villiers, L S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-65747d21dfb2c473f5deff474b76edcb8ad2b6b61770bd2668495435a7e104843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adult</topic><topic>Arteriosclerosis - drug therapy</topic><topic>Cholesterol - analysis</topic><topic>Cholesterol, HDL</topic><topic>Cholesterol, LDL</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Humans</topic><topic>Lipoproteins, HDL - analysis</topic><topic>Lipoproteins, HDL - blood</topic><topic>Lipoproteins, LDL - analysis</topic><topic>Male</topic><topic>Vitamin E - pharmacology</topic><topic>Vitamin E - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serfontein, W J</creatorcontrib><creatorcontrib>Ubbink, J B</creatorcontrib><creatorcontrib>de Villiers, L S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serfontein, W J</au><au>Ubbink, J B</au><au>de Villiers, L S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Further evidence on the effect of vitamin E on the cholesterol distribution in lipoproteins with special reference to HDL subfractions</atitle><jtitle>American journal of clinical pathology</jtitle><addtitle>Am J Clin Pathol</addtitle><date>1983-05</date><risdate>1983</risdate><volume>79</volume><issue>5</issue><spage>604</spage><epage>606</epage><pages>604-606</pages><issn>0002-9173</issn><eissn>1943-7722</eissn><abstract>Earlier claims that oral administration of alpha-tocopherol results in significant and considerable increase in the serum total HDL concentration could not be substantiated. The present investigation does, however, show that lipoproteins are affected by alpha-tocopherol in other ways, the main effects being an increase in LDL-cholesterol and also in the HDL3-V cholesterol, an HDL3-subfraction determined by polyacrylamide gel electrophoresis. The established lipoprotein risk indices (LDL/HDL and HDL3/HDL2 ratios) were unfavorably affected as a result of alpha-tocopherol treatment. It is concluded that on the basis of available evidence, there is no reason to believe that alpha-tocopherol has a role to play in the prevention and treatment of atherosclerotic disease.</abstract><cop>England</cop><pmid>6837523</pmid><doi>10.1093/ajcp/79.5.604</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9173
ispartof American journal of clinical pathology, 1983-05, Vol.79 (5), p.604-606
issn 0002-9173
1943-7722
language eng
recordid cdi_proquest_miscellaneous_80439548
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Adult
Arteriosclerosis - drug therapy
Cholesterol - analysis
Cholesterol, HDL
Cholesterol, LDL
Electrophoresis, Polyacrylamide Gel
Humans
Lipoproteins, HDL - analysis
Lipoproteins, HDL - blood
Lipoproteins, LDL - analysis
Male
Vitamin E - pharmacology
Vitamin E - therapeutic use
title Further evidence on the effect of vitamin E on the cholesterol distribution in lipoproteins with special reference to HDL subfractions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T12%3A31%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Further%20evidence%20on%20the%20effect%20of%20vitamin%20E%20on%20the%20cholesterol%20distribution%20in%20lipoproteins%20with%20special%20reference%20to%20HDL%20subfractions&rft.jtitle=American%20journal%20of%20clinical%20pathology&rft.au=Serfontein,%20W%20J&rft.date=1983-05&rft.volume=79&rft.issue=5&rft.spage=604&rft.epage=606&rft.pages=604-606&rft.issn=0002-9173&rft.eissn=1943-7722&rft_id=info:doi/10.1093/ajcp/79.5.604&rft_dat=%3Cproquest_cross%3E80439548%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80439548&rft_id=info:pmid/6837523&rfr_iscdi=true